Sun Pharma falls as USFDA investigates Mohali plant Sun Pharma falls as USFDA investigates Mohali plant Dnyanada Kulkarni / Wednesday, September 12, 2018 0 3710 Article rating: 4.3 Sun Pharma’s Mohali plant in Punjab is undergoing a three-day surprise investigation by the USFDA. The investigation commenced on September 10, 2018, confirmed the company in an exchange filing. The company is of the opinion that the investigation will not cause any material impact. Read more
Antiretroviral drug of Cipla receives approval from South African regulator Antiretroviral drug of Cipla receives approval from South African regulator Gayathri Udyawar / Wednesday, September 12, 2018 0 1175 Article rating: 5.0 Cipla’s first-line triple-combination treatment for HIV receives approval from the South African Health Products Regulatory Authority (SAHPRA). The newly developed combination drug will be produced locally for the African market. Read more
Narayana Hrudayalaya gains as arm ties-up with Bangladesh-based hospital Narayana Hrudayalaya gains as arm ties-up with Bangladesh-based hospital Sanket Dewarkar / Wednesday, September 12, 2018 0 1602 Article rating: 2.5 Narayana Hrudayalaya’s step-down subsidiary, NH Health Bangladesh, has entered into definitive agreements to partner with Imperial Hospital in Chittagong, Bangladesh to operate and manage their cardiac sciences department. Read more
Five stocks with selling interest Five stocks with selling interest Shital Jibhe / Wednesday, September 12, 2018 0 1976 Article rating: 5.0 Overall volumes in futures & options currently stand at 1.24 crore contracts with a turnover of Rs. 12,62,935.13 crore. Read more
Five stocks with buying interest Five stocks with buying interest Shital Jibhe / Wednesday, September 12, 2018 0 1823 Article rating: 4.0 Overall volumes in futures & options currently stand at 1.24 crore contracts with a turnover of Rs. 12,62,935.13 crore. Read more